Relationships Between Vitamin D₃ and Metabolic Syndrome
Overview
Public Health
Authors
Affiliations
The growing number of overweight and obese individuals is an alarming global problem; these conditions are risk factors for the development of health problems such as metabolic syndrome (MetS), type-2 diabetes, atherosclerosis, and cardiovascular disease. Numerous studies have suggested that vitamin D₃ deficiency plays a role in the pathogenesis of MetS. The aim of this study was to analyze the relationship between MetS and vitamin D₃ levels in women. Laboratory analysis demonstrated that only 26.89% of the participants had vitamin D₃ levels close to normal, and waist-to-hip ratio (WHR) measurements revealed android obesity in 75.63% of the women. The menstruating women more often suffered from vitamin D₃ deficiency, and less often had elevated vitamin D₃ levels. The conclusions are as follows: (1) There were no statistically significant relationships between vitamin D₃ levels and MetS parameters, namely the level of triglycerides, the levels of low- and high-density lipoproteins (LDL and HDL), the level of total cholesterol, and systolic and diastolic blood pressure (SBP and DBP). Vitamin D deficiency was only observed in the women with abdominal obesity. (2) Low vitamin D₃ levels were typical of perimenopausal women. Age was a variable correlating with vitamin D. (3) The presence of menstrual cycles was an important contributor to vitamin D levels. Vitamin D deficiency was significantly more common in the menstruating women.
Ahluwalia N, Raghavan R, Zhang G, Talegawkar S, Jacques P Am J Clin Nutr. 2022; 116(5):1400-1408.
PMID: 36036472 PMC: 10474946. DOI: 10.1093/ajcn/nqac234.
The effect of iron dextran on vitamin D metabolism in SD rats.
Qiu F, Li R, Gu S, Zhao Y, Yang L Nutr Metab (Lond). 2022; 19(1):47.
PMID: 35842653 PMC: 9288701. DOI: 10.1186/s12986-022-00681-5.
Yang Z, Wei X, Fu B, Chen J, Yu D Front Nutr. 2022; 9:822376.
PMID: 35284455 PMC: 8905503. DOI: 10.3389/fnut.2022.822376.
Reviewing the Significance of Vitamin D Substitution in Monoclonal Gammopathies.
Innao V, Allegra A, Ginaldi L, Pioggia G, De Martinis M, Musolino C Int J Mol Sci. 2021; 22(9).
PMID: 34066482 PMC: 8124934. DOI: 10.3390/ijms22094922.
Sadeghi O, Sadeghi A, Mozaffari-Khosravi H, Shokri A Public Health Nutr. 2020; 24(11):3379-3388.
PMID: 32641199 PMC: 10195254. DOI: 10.1017/S1368980020001639.